Improving Heart Function (iHF)

#ACS complicated by cardiogenic shock remains one of the most critical scenarios in cardiology. In this #iHFCourse session, the multidisciplinary panel highlights the need for early recognition, rapid stratification & shock team coordination. Watch 👉 brnw.ch/21x27Ly

From #PVCs to cardiomyopathy, understanding recovery remains a key clinical challenge. In this #iHFCourse interview, @ShelleyZieroth and @joselmerino discuss important prognostic factors like ECG features, #PVC morphology and frequency. Replay session: brnw.ch/21x22Rm

Join @valeriaparadies for the next #PCRWebinar "Preventing and treating acute heart failure in STEMI patients" 📅 Friday 24 April at 4:00pm (UTC+2) Register for free: pcronline.com/Webinars/PCR-W… @VPanoulas @sinning_jan

🔎 How to find the right time for the right patient regarding mitral regurgitation in #HFrEF? @AlexMebazaa interviews Michael Boehm about the best indicators for M-TEER and the optimal timing for intervention. Watch #iHFCourse expert panel discussion: brnw.ch/21x1Nv5

Treating aortic stenosis goes beyond the valve itself. In this interview from #iHFCourse 2026, @IUchmanowicz & @S_Raposeiras highlight the need for a holistic approach to address myocardial involvement and HF risk. 🔗 Full session replay: brnw.ch/21x1Gnj #CardioEd #TAVI

📊The DARE-AF trial published in @CircAHA explored whether Dapagliflozin, an SGLT2 inhibitor, can reduce AF recurrence post-ablation in patients without typical indications for the drug. Unlike earlier studies involving patients with conditions like heart failure or type 2 diabetes, this trial focused on 200 patients set for ablation without these comorbidities. In our Journal Club video, @ShelleyZieroth reviews the findings and their significance for SGLT2 inhibitors in new patient groups. Watch to learn more about the study design and outcomes⤵️

In this interview from the #iHFCourse, @Dr_Owais_Dar Dar and Antoine Kimmoun delve into the crucial role of inotropes in managing cardiogenic shock. Join us to discover why Dobutamine is considered the primary inodilator for this condition, and gain valuable insights into optimal dosing strategies. ▶️Watch Now: iheartfunction.com/cases-resource…

PVCs in heart failure: what to treat medically, ablate, or leave alone 
Ahead of this #iHFCourse session, @DavidDuncker shares a preview of the discussion and the case he will present.
 ▶️Join us live at 12:15: iheartfunction.com/course/ihf-cou…

🔴#IHFCourse 2026 is Live! Join us for an interactive session here or on the website: iheartfunction.com/course/ihf-cou… twitter.com/i/broadcasts/1…

It's the end of Day 1⃣ of #iHFCourse and after an intense couple of hours spent learning & sharing, it's time for a well-deserved moment of relaxation 😊 See you online 📺📱 tomorrow at 08h30 for Day 2! iheartfunction.com/course/ihf-cou…

🎤Following the session on “Precision pathways in patients with aortic stenosis awaiting #TAVI: act beyond symptoms” at #iHFCourse, @EGallinoro spoke with @GMCRosano to reflect on the key takeaways.
 🔎A focused look at patient management beyond symptom presentation. Replay soon available on iheartfunction.com!

Following an engaging session on “ACS with cardiogenic shock” at #iHFCourse, @EchoSoliman spoke with Marina Clément about the main discussion points⬇️

🔴#IHFCourse 2026 is Live! Join us for an interactive session here or on the website: iheartfunction.com/course/ihf-cou… twitter.com/i/broadcasts/1…

⌛#iHFCourse 2026 is about to start! Join us for a unique, trans-disciplinary course dedicated to #heartfailure management, bringing together interventional cardiology, electrophysiology, imaging and advanced HF care. Free access here➡️iheartfunction.com/course/ihf-cou…

Join us online from 13h20 as we kick off #iHFCourse, the trans-disciplinary course for those interested in heart failure drugs and device solutions to improve patient care! It will be online here ➡️ iheartfunction.com/course/ihf-cou… (partiipation is free)

#iHFCourse 2026 starts very soon ⌛ An 8-session curriculum covering key aspects of #heartfailure care. Join us this Friday at 13:20: iheartfunction.com/course/ihf-cou… Free and open to all HF specialists!

Something big is happening in Paris today: it's day 1⃣ of #iHFCourse, the only trans-disciplinary Course on heart failure management! Check out the programme here and join us online at any time to participate in an innovative blended educational format ➡️iheartfunction.com/course/program… See you online as from 13h20 Paris time today! #improvingheartfunction

Join me online for #iHFCourse! Fri. 20/03 15:00 - 16:00 Precision pathways in patients with aortic stenosis awaiting TAVI and Sat. 21/03 9:45 - 10:45 From drug escalation to CIED implantations in atypical HFrEF iheartfunction.com/course/program… #heartfailure @iheartfunction

I’m pleased to be part of the inaugural #iHFCourse 2026! Join me online to discuss “ACS with cardiogenic shock: challenging clinical settings in need of trans-disciplinary management” On 20/03 from 13:45 - 14:45 CET. Free registration here: iheartfunction.com/course/registr… @iheartfunction #MedEd #ECMO #MCS #echofirst

Kidney dysfunction is common after HT. In this review, we discuss mitigating strategies including immunosuppression & nephroprotective medications for HT recipients @shannonmdunlay @KBreathettMD @KhazanieHeart @RichardKCheng2 @elenamdonald @EMDeFilippisMD ahajrnls.org/4sO9XkR